A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19)

Am J Trop Med Hyg. 2020 May;102(5):932-933. doi: 10.4269/ajtmh.20-0230.
No abstract available

MeSH terms

  • Antimalarials* / adverse effects
  • Antimalarials* / therapeutic use
  • Betacoronavirus*
  • COVID-19
  • COVID-19 Drug Treatment
  • Chloroquine* / adverse effects
  • Chloroquine* / therapeutic use
  • Coronavirus Infections / drug therapy*
  • Humans
  • Hydroxychloroquine* / adverse effects
  • Hydroxychloroquine* / therapeutic use
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Randomized Controlled Trials as Topic*
  • SARS-CoV-2

Substances

  • Antimalarials
  • Hydroxychloroquine
  • Chloroquine